id | C00018091 |
---|---|
Name | MM 14151 / BRL 14151 / Clavulanic acid / Antibiotic MM 14151 |
CAS RN | 58001-44-8 |
Standard InChI | InChI=1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13)/b4-1-/t6-,7-/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13) |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 6487 |
By standard InChI | CHEMBL777 |
---|---|
By standard InChI Main Layer | CHEMBL777 CHEMBL1625527 |
By LinkDB | C06662 |
---|
By CAS RN | D019818 |
---|
class name | count |
---|
family name | count |
---|---|
Streptomycetaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Streptomyces clavuligerus ATCC 27064 | 443255 | Streptomycetaceae | Bacteria |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL777 |
CHEMBL2071965
(1)
|
1 / 0 |
P08246 | Neutrophil elastase | S1A | CHEMBL777 |
CHEMBL676197
(1)
|
2 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL777 |
CHEMBL2071963
(1)
|
0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL777 |
CHEMBL2071962
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL777 |
CHEMBL2071964
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL777 |
CHEMBL2071966
(1)
CHEMBL2071967
(1)
|
0 / 1 |
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D000799 | D019818 | Angioedema |
marker/mechanism
|
19080805
|
|
D002779 | D019818 | Cholestasis |
marker/mechanism
|
2791808
|
|
D004342 | D019818 | Drug Hypersensitivity |
marker/mechanism
|
19080805
|
|
D056486 | D019818 | Drug-Induced Liver Injury |
marker/mechanism
|
2791808
|
|
D005076 | D019818 | Exanthema |
marker/mechanism
|
2791808
|